166 related articles for article (PubMed ID: 23010614)
1. The impact of preoperative immunonutrition and other nutrition models on tumor infiltrative lymphocytes in colorectal cancer patients.
Caglayan K; Oner I; Gunerhan Y; Ata P; Koksal N; Ozkara S
Am J Surg; 2012 Oct; 204(4):416-21. PubMed ID: 23010614
[TBL] [Abstract][Full Text] [Related]
2. Decrease in intrahepatic CD56+ lymphocytes in gastric and colorectal cancer patients with liver metastases.
Gulubova M; Manolova I; Kyurkchiev D; Julianov A; Altunkova I
APMIS; 2009 Dec; 117(12):870-9. PubMed ID: 20078551
[TBL] [Abstract][Full Text] [Related]
3. [Effects of various feeding regimens in multiple trauma patients on septic complications and immune parameters].
Engel JM; Menges T; Neuhäuser C; Schaefer B; Hempelmann G
Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Apr; 32(4):234-9. PubMed ID: 9289023
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cells infiltrating colorectal cancer and MHC class I expression.
Sandel MH; Speetjens FM; Menon AG; Albertsson PA; Basse PH; Hokland M; Nagelkerke JF; Tollenaar RA; van de Velde CJ; Kuppen PJ
Mol Immunol; 2005 Feb; 42(4):541-6. PubMed ID: 15607811
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
6. Dietary supplementation with L-arginine: modulation of tumour-infiltrating lymphocytes in patients with colorectal cancer.
Heys SD; Segar A; Payne S; Bruce DM; Kernohan N; Eremin O
Br J Surg; 1997 Feb; 84(2):238-41. PubMed ID: 9052446
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells.
Diederichsen AC; Hjelmborg Jv; Christensen PB; Zeuthen J; Fenger C
Cancer Immunol Immunother; 2003 Jul; 52(7):423-8. PubMed ID: 12695859
[TBL] [Abstract][Full Text] [Related]
8. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
[TBL] [Abstract][Full Text] [Related]
9. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT
Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells.
Dadabayev AR; Sandel MH; Menon AG; Morreau H; Melief CJ; Offringa R; van der Burg SH; Janssen-van Rhijn C; Ensink NG; Tollenaar RA; van de Velde CJ; Kuppen PJ
Cancer Immunol Immunother; 2004 Nov; 53(11):978-86. PubMed ID: 15197496
[TBL] [Abstract][Full Text] [Related]
11. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.
Salama P; Phillips M; Grieu F; Morris M; Zeps N; Joseph D; Platell C; Iacopetta B
J Clin Oncol; 2009 Jan; 27(2):186-92. PubMed ID: 19064967
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
13. Activation of tumor-specific T lymphocytes after laser-induced thermotherapy in patients with colorectal liver metastases.
Vogl TJ; Wissniowski TT; Naguib NN; Hammerstingl RM; Mack MG; Münch S; Ocker M; Strobel D; Hahn EG; Hänsler J
Cancer Immunol Immunother; 2009 Oct; 58(10):1557-63. PubMed ID: 19184001
[TBL] [Abstract][Full Text] [Related]
14. Tumor-associated antigen recognized by the 22-1-1 monoclonal antibody encourages colorectal cancer progression under the scanty CD8+ T cells.
Oshikiri T; Miyamoto M; Morita T; Fujita M; Miyasaka Y; Senmaru N; Yamada H; Takahashi T; Horita S; Kondo S
Clin Cancer Res; 2006 Jan; 12(2):411-6. PubMed ID: 16428480
[TBL] [Abstract][Full Text] [Related]
15. T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases.
Katz SC; Pillarisetty V; Bamboat ZM; Shia J; Hedvat C; Gonen M; Jarnagin W; Fong Y; Blumgart L; D'Angelica M; DeMatteo RP
Ann Surg Oncol; 2009 Sep; 16(9):2524-30. PubMed ID: 19568816
[TBL] [Abstract][Full Text] [Related]
16. High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer.
Piersma SJ; Jordanova ES; van Poelgeest MI; Kwappenberg KM; van der Hulst JM; Drijfhout JW; Melief CJ; Kenter GG; Fleuren GJ; Offringa R; van der Burg SH
Cancer Res; 2007 Jan; 67(1):354-61. PubMed ID: 17210718
[TBL] [Abstract][Full Text] [Related]
17. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
18. Metabolic and immune effects of dietary arginine, glutamine and omega-3 fatty acids supplementation in immunocompromised patients.
Chuntrasakul C; Siltharm S; Sarasombath S; Sittapairochana C; Leowattana W; Chockvivatanavanit S; Bunnak A
J Med Assoc Thai; 1998 May; 81(5):334-43. PubMed ID: 9623033
[TBL] [Abstract][Full Text] [Related]
19. Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome.
Daly JM; Lieberman MD; Goldfine J; Shou J; Weintraub F; Rosato EF; Lavin P
Surgery; 1992 Jul; 112(1):56-67. PubMed ID: 1377838
[TBL] [Abstract][Full Text] [Related]
20. Perioperative immunonutrition ameliorates the postoperative immune depression in patients with gastrointestinal system cancer (prospective clinical study in 42 patients).
Ateş E; Yilmaz S; Erkasap S; Ihtiyar E; Kaya Y; Pehlivan T; Ustuner Z; Yasar B; Kiper H
Acta Gastroenterol Belg; 2004; 67(3):250-4. PubMed ID: 15587331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
